Concepedia

Christopher Hoimes

CH

77

Publications

7K

Citations

39

H-Index

2008

Active since

Affiliations

University Hospitals Seidman Cancer Center(Current)

Case Western Reserve University

Duke Medical Center

Memorial Sloan Kettering Cancer Center

Merck & Co., Inc., Rahway, NJ, USA (United States)

Christopher Hoimes is an author at University Hospitals Seidman Cancer Center specializing in medicine, cancer therapeutics, and urology.

ORCID

Top concepts

Publications per year

2008–2024

77

Publications

77

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma

Thomas Powles, Peter H. O’Donnell, Christophe Massard et al. · JAMA Oncology · 2017 · 839 citations · Full text

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

Emmanuel S. Antonarakis, Josep M. Piulats, Marine Gross‐Goupil et al. · Journal of Clinical Oncology · 2019 · 679 citations · Full text

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2020 · 619 citations · Full text

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2019 · 549 citations · Full text

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

Philippe E. Spiess, Neeraj Agarwal, Rick Bangs et al. · Journal of the National Comprehensive Cancer Network · 2017 · 276 citations · Full text

, , +14

Rows per page

1–5 of 77